From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area.
Key Features
- Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care.
- Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care.
- Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon.
- Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.
| ISBN | 9780323755979 |
|---|---|
| Author Information | Edited by Daniel W. Lee and Nirali N. Shah, Lasker Clinical Research Scholar, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, United States |
| Table of Content | Introduction |
| Publication Date | 30-11-2019 |
| Pages | 230 |
| Trim | 235 x 191 (7 1/2 x 9 1/4) |
| deltacomm1code | Electronic Book |
